The total return over the past 12 months is +111.04% vs. +16.94% for the S&P 500. So far it's up +134.16% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +111.04% | (7.61%) | (28.42%) | (18.75%) | N/A | N/A |
| Total Return CAGR | +111.04% | (7.61%) | (28.42%) | (18.75%) | N/A | N/A |
| Revenue CAGR | +2.32% | +3.22% | +7.33% | +4.84% | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
MacroGenics, Inc. (MGNX)
| Year | Start price | End price | MGNX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.61 | $3.77 | +134.16% | +14.51% | +119.65% |
| 2025 | $3.25 | $1.61 | (50.46%) | +17.72% | (68.18%) |
| 2024 | $9.62 | $3.25 | (66.22%) | +24.89% | (91.11%) |
| 2023 | $6.71 | $9.62 | +43.37% | +26.19% | +17.18% |
| 2022 | $16.05 | $6.71 | (58.19%) | (18.17%) | (40.02%) |
| 2021 | $22.86 | $16.05 | (29.79%) | +28.74% | (58.53%) |
| 2020 | $10.88 | $22.86 | +110.11% | +18.37% | +91.74% |
| 2019 | $12.70 | $10.88 | (14.33%) | +31.22% | (45.55%) |
| 2018 | $19.00 | $12.70 | (33.16%) | (4.56%) | (28.60%) |
| 2017 | $20.44 | $19.00 | (7.05%) | +21.70% | (28.75%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
